Results 131 to 140 of about 1,435 (159)

Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and Efficacy.

open access: yesHorm Res Paediatr
Stawerska R   +11 more
europepmc   +1 more source

Predictors of Fracture in Middle-Aged and Older Adults With Type 2 Diabetes and Overweight or Obesity.

open access: yesJ Clin Endocrinol Metab
Elam RE   +5 more
europepmc   +1 more source

Inhibition of lysosomal degradation increases expression of mutant ADA2 in DADA2 monocytes.

open access: yesJ Allergy Clin Immunol
Ehlers L   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy